U.S. appeals court invalidates Acorda patents on MS drug Medical Dialogues Bureau11 Sept 2018 9:00 AM ISTA U.S. appeals court on invalidated Acorda Therapeutics Inc patents covering its multiple sclerosis drug Ampyra, opening the door for generic...
Glenmark Pharma arm gets approval for generic asthma drug in Germany Medical Dialogues Bureau10 Sept 2018 10:30 AM ISTNew Delhi: Glenmark Pharma's subsidiary has secured marketing authorization in Germany for the generic version of GlaxoSmithKline's Seretide...
Roche faces UK pricing row over multiple sclerosis drug Ocrevus Medical Dialogues Bureau10 Sept 2018 10:00 AM ISTLONDON: Roche faces a fresh row over drug pricing in Britain, following a decision by the body responsible for medicine use within the state health...
US redirecting 25 million dollar in aid for East Jerusalem hospitals Medical Dialogues Bureau10 Sept 2018 9:45 AM ISTWashington: The Trump administration said that it is cutting USD 25 million meant for East Jerusalem hospitals and putting the money toward...
Maryland charges Insys with engaging in deceptive opioid scheme Medical Dialogues Bureau10 Sept 2018 9:30 AM ISTMaryland charged Insys Therapeutics Inc with deceptively marketing a powerful opioid painkiller so that it was prescribed inappropriately beyond its...
Opposing Online Pharmacies, 8.5 lakh chemists to call it a strike on September 28 Ruby Khatun Khatun9 Sept 2018 10:55 AM ISTNew Delhi: In order to protest against the government decision to permit e-pharmacies, AIOCD, a representative body of around 8.5 lakh chemists in the...
USFDA completes inspection at Caplin Point Lab's sterile injectable facility in Tamil Nadu Medical Dialogues Bureau9 Sept 2018 10:45 AM ISTNew Delhi: Caplin Point Laboratories said the US health regulator has completed the inspection at its sterile injectable facility in Gummudipoondi in...
FDA approves Cassipa as maintenance treatment for opioid dependence Ruby Khatun Khatun9 Sept 2018 10:00 AM ISTThe U.S. Food and Drug Administration (FDA) approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the...
AstraZeneca gets FDA breakthrough therapy label for asthma treatment Ruby Khatun Khatun9 Sept 2018 9:45 AM ISTAstraZeneca Plc and Amgen Inc said the U.S. Food and Drug Administration had granted a breakthrough therapy label for their drug to treat a type of...
Pfizer terminates Domagrozumab clinical studies for Duchenne muscular dystrophy Ruby Khatun Khatun9 Sept 2018 9:30 AM ISTNew York: Pfizer Inc. announced today that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of...
Supreme Court restrains Ministry of Health from taking a call on 15 banned FDC drugs Ruby Khatun Khatun8 Sept 2018 6:13 PM ISTThe 15 FDCs include those of big brands like Abbott Healthcare's Phensydyl, Paras Pharmaceutical's D-Cold Tablet, Alkem's Sumo, Franco-Indian...
Sun Pharma gets 6 observations by USFDA for its Halol facility Ruby Khatun Khatun8 Sept 2018 11:01 AM ISTNew Delhi: Drug major Sun Pharmaceutical Industries said the US health regulator has issued Form 483 with six observations after an inspection of its...
